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AbstrAct
Background: Adolescents have risky sexual behaviour exposing them to the human 
papilloma virus (hpv) infection. With  clear causal relationship between high risk the 
hpv (16 and 18) infection and  invasive cancer, this study focuses on the distribution 
of hpv genotypes among the female adolescent and youth at the Kenyatta National 
hospital (KNh) youth clinic. 
Objective: to determine DNA genotype of hpv infection among adolescent girls at 
KNh - youth clinic and use it as an advocacy tool for the introduction of the hpv 
vaccine provision in the clinic.  
Design: cross-sectional study. 
Setting: Kenyatta National hospital youth clinic. 
Subjects: Adolescent (and youths) girls aged between 12-24 years.  
Results: two hundred and sixty four participants were recruited into the study for a 
period of three months. the recruitment was done in the clinic till the required sample 
size was obtained. the prevalence of cervical hpv infection was 9.8% (95% ci: 6.13 to 
13.41). there were multiple serotypes with 27% infected with hpv strain type 18 and 
66. type 16 was 5%, type 18 was 9%, and there were mixed genotype infections in the 
rest. there were no low risk strains isolated and 18% of the respondents who tested 
positive for hpv DNA had uncharacterised strains.
Conclusion: the prevalence of hpv among the adolescent girls at KNh youth clinic 
was 9.8%.  twenty seven percent had co-infection with type 18 and 66. 
iNtroDuctioN
human papilloma virus (hpv) is a common sexually 
transmitted viral infection. it is estimated that at 
least 50% of women will be infected with hpv in 
their lifetime (1).  Worldwide it is estimated to affect 
291 million women, 105 million being infected with 
the high risk serotypes 16 and 18 (2).  the annual 
incidence is estimated at 371,000 worldwide (2, 3). 
the prevalence rates vary from region to region; 
with estimated rates of 1.4 to 25.6 % in asymptomatic 
women (4). the World health organisation estimates 
an overall prevalence of  22 % of hpv infection in 
African countries (5).  rates in Kenyan are unknown 
although studies among men in high endemic areas 
have been reported at 50% (6). the distribution of hpv 
types is also variable. the distribution in invasive 
lesions  in order of reducing prevalence are: 16 ,18 ,33 
,45 ,31 ,58 , 52 , 35 , 59 , 56 , 51 , 39 , 6 , 68 , 73 , 66 , 70. 
(7, 8). hpv type 16 is consistently the most common 
serotype in high grade and invasive lesions (8).  the 
prevalence of high risk serotypes in most adolescent 
populations has been found to be low with rates of 
3.4 % or less while low risk serotypes constitute the 
majority (9,10).  Among the low risk serotypes, hpv 6 
and 11 are the most common estimated to cause more 
than 90% of genital warts (4,6,11,) and 25 % of ciN 
i, whereas high risk types account for the remaining 
75% of ciN i. infection with multiple serotypes is 
common occurring in 20-30 % of women (12, 13).
 Age is an important factor in hpv infection, the 
highest prevalence and incidence rates being among 
adolescents’ prevalence rates exceeding 30% in most 
high risk adolescent populations ((3, 14, 15,) there is a 
linear increase in prevalence by age from 14-25 years with 
the peak prevalence at 20- 24 years which then declines 
with advancing age though some societies demonstrate 
a second peak after the age of sixty  years.  
192 East african MEdical Journal June 2011 
 in adolescent girls increased incidence is 
associated with early onset of sexual activity, multiple 
sexual partners, presence or a history of sexually 
transmitted infections, anal intercourse, smoking 
(13,14,16) and less consistently: frequent sexual 
intercourse , use of combined oral contraceptives, 
pregnancy  and abortions (15 - 19). having a sexual 
partner who has multiple partners, (20) homosexuals 
and non-frequent condom users are also at increased 
risk (21). risk factors for infection in men are similar 
to those in girls (22,23). lack of circumcision is an 
additional risk factor both for men and their sexual 
partners (24, 25).  since the adolescent girls are at 
a risk of hpv infection, a primary prevention can 
be achieved by hpv vaccine administration to the 
prepubertal girls and those who are not yet sexually 
active. in a study done in 2010, among the parents 
of the adolescent girls in Nairobi, only 58% accepted 
vaccine administration to their daughters. this is of 
concern since vaccination may prevent hpv infection 
and development of invasive cervical cancer (16).   
 hpv is a double stranded DNA virus belonging 
to the papovovirus family, with more than 100 hpv 
serotypes, 40 of which infect the genital tract of both 
men and women. the virus infects both keratinised 
and non-keratinised epithelia such as anogenital 
tract, oropharynx and lungs, prostate and skin.  hpv 
can broadly be grouped into cutaneous and mucosal 
types according to their site of infection, and can be 
further subdivided into low-risk (lr) and high-risk 
(hr) types depending upon their association with 
malignancy. high risk hpv types 16 and 18 have been 
conclusively shown to be associated with invasive 
cancer of the cervix in 70% of cases (26).
 the main route of transmission of high risk (hr) 
mucosal hpvs is through sexual contact, although the 
acquisition of the virus cannot be entirely explained by 
this mode alone. there is evidence of both horizontal 
and vertical transmission. hr hpvs, particularly 
hpv-16, have been detected in oral swabs from new-
borns, infants and children (14, 28, 29).
 hiv infection does play an important role in 
the progression of hpv infection to invasive cancer 
(26). there is, therefore, a need to determine hiv 
serostatus in all people with hpv infection (30,31). 
the adolescents are a vulnerable group for hpv and 
hiv infection, to their behavioural attitudes and peer 
pressure. it is, therefore, important to determine the 
prevalence of hr hpv infection in this age group. 
this will help in strengthening the need for advocacy 
for introduction of hpv vaccine use from this age 
group. most hpv infections are sub-clinical and 
transient; about 90 % will resolve within nine months 
but may last up to two years (3, 14, 32, and 33) due 
to development of cell mediated immunity. After 
infection hpv remains in a quiescent state that lasts 
two to twelve month then is either cleared or persists 
below sensitivity level (latent phase). About 10-20 
% of infections may persist and develop into genital 
warts or ciN 1 within three to six months. most of 
this regress but some may progress to pre-cancer 
lesions (CIN 2, 3) in four to five years (33, 34).  Some 
high grade lesions may arise directly from initial hpv 
infection (10). progression to invasive cancer takes 
one to fifteen years; the development of invasive 
cancer is age related with peaks at 50 years, ciN i at 
28 years and ciN 2, 3 at 42 years (15, 34). the trends 
seen in our region show that development of invasive 
cancers occurs at an earlier age.
mAteriAl AND methoD
Study population: these were adolescent/young girls 
aged 12-26 years who attended the youth clinic within 
the study period. the clinic attends to an average 
of 600 adolescent and youths per month,(60%  are 
females), who present for various reasons including 
seeking treatment for sexually transmitted infections, 
drug abuse, teenage pregnancies and consultation 
for menstrual abnormalities among others. All 
adolescents/young females who were eligible and 
gave an informed consent or those whose parents 
or guardians were available to give the written 
consent were recruited into the study.  each client 
was individually counselled and informed consent 
was obtained. simple random sampling was used, 
every third female client reporting to the youth centre 
and met the inclusion criteria and consented was 
recruited into the study. 
 A questionnaire was administered in the clinic 
in a private room before she was attended to by the 
clinic doctor and the following information was 
obtained; respondent’s characteristics- age, marital 
status, level of education, gynaecological history, 
sexual history and social history, knowledge on hpv 
transmission. consequences of hpv infection and 
prevention.  the specimen collection procedure was 
explained and the clients were directed to a private 
room for specimen collection. the client was put in 
lithotomy position, sterile procedures were observed, 
speculum was introduced into the vagina and a 
cervical swab was taken by using a cervical brush 
to determine the presence and  genotype of hpv 
infection. the swabs were placed in a labeled glass 
tube containing a preservative and stored in a cold box. 
the cold box containing specimens was transported 
to Kemri hpv laboratory for DNA analysis on the 
same day of collection within 15 hours. laboratory 
forms accompanying participant’s specimen were 
given unique number for each of the respondents. 
this unique number was also labeled clearly in the 
respondent questionnaire.
processing of the cervical swab for hpv
DNA Extraction: the extraction of the DNA was 
carried out using the Al Buffer as a lytic buffer to the 
June 2011 East african MEdical Journal   193
cervical cell previously obtained from the respondent. 
the proteinase K was introduced into the sample for 
the purpose of destruction of the rNA found in the 
cell contents to its respective bases. introduction of 
absolute ethanol brought about precipitation of all 
the proteins in the mixture that was then followed 
by centrifugation of the same so as to sediment the 
proteins. the supernatant which contains the DNA 
templates and the suspended bases of the destroyed 
rNA were then subjected to the spin column onto 
which the DNA absorbed as the rest of the stuff is 
washed down the column into the collecting tube. 
After washing the absorbed DNA twice with AW1 
and AW2 respectively, the DNA was then eluded 
into a 1.5ml eppendoff tube using the Ae buffer or 
distilled water. HPV amplification was then done 
using a thermo cycler that uses the pre-programmed 
thermocyclic cycles ranging in temperatures from 
950c, 500c, 720c, and 40c respectively till the DNA 
templates of interests’ desired detectable range was 
achieved. 
Quality Assurance: the laboratory number of 
the specimen was counter checked to ensure 
correspondence. the standardised protocol from 
QiAgeN that is internationally recognised was 
used for processing the samples for DNA extraction, 
amplification, electrophoresis and detection of HPV. 
genotyping of various types of hpv was done by 
using the standardised protocol for hybridisation.
Data Management: Data entry and cleaning was done, 
each entry had the unique study number so as to 
protect the privacy of the study participants. the 
information was stored and analysed using statistical 
package for social scientists version 17 (spss, 
chicago). the data collection questionnaires were 
filed and stored in a safe cabinet where verification 
of results can be done whenever necessary. 
Ethical considerations: Approval from Kenyatta 
National hospital and university of Nairobi ethics 
and research committee was granted for the study. 
results
A total of 264 female participants were recruited into 
the study. seven did not have hpv results. the mean 
age was 22.6 years (sD=23 years) (table 1).
table 1
Demographic characteristics of the adolescents that participated in the study
patient characteristic hpv negative hpv positive 
median age (min, max) n=256 22.7 (16,25) 22.0 (17,25)
marital status n(%) n(%)
single cohabiting  79(34)  10(40)
single not cohabiting  119(52)  13(52)
married  28(12)  0
Divorced  3(1)  1(4)
Widowed  2(1)  1(4) 
education level   
primary  19(8.3)  1(4)
secondary  19(8.3)  2(8)
college  185(81.1)  21(84)
university  5(2.2) 1(4) 
spouse’s education level   
None  2  0
primary  6  0
secondary  12  0
tertiary  48  8
university  3  0















most of the study participants had college education. 
those who were single and yet cohabiting were 
34.8%. the majority of the respondents (86.3%) were 
single. 
out of the 256 participants who were tested, 25 (9.77%) 
had positive hpv DNA results. the prevalence of 
hpv infection was found to have been 9.77% (95% 
ci: 6.13 to 13.41).this has been illustrated in (fig 1).
figure 1
Prevalence of HPV infection among adolescents at KNH (n=256)
figure 2
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most of the participants, who were positive, had 
multiple serotypes, with 27% infected with hpv strain 
type 18 and 66. there were no low risk strains isolated 
and 18% of the respondents who tested positive for 
hpv DNA had uncharacterised strains.  infection 
with mixed strains was also found.
table 2
Association between sexual behaviour and HPV status
 hpv negative n, (%) hpv positive n, (%) p-value
Age at first sexual intercourse   0.273
  <10 years 2(1)  1(4)
  10-15 years 31(14) 2(9)
  >15 years 189(85)  20(87)
  missing/unknown  9 2
Number of lifetime partners   0.882
 <2 138(63)  14(67) 
 3-5  60(27)  6(28)
 >5 22(10)  1(5)
 missing/unknown  11  4 
sexual partners in the past  six months    >0.999
 2  189(88)  20(91)
 3-5 21(10)  2(9)
 >5 4(2)  0
 missing/unknown 17  3 
 frequency of intercourse per week
 ≤1 147(69)  17(89) 0.164
 2-3 42(19)  1(5.5)
 >3 25(12)  1(5.5)
 missing/unknown  17 6 
practice douching after sex   0.446
 yes  46(22)  6(32)
 No  161(78)  13(68)
 missing/unknown 24  6 
ever treated for an sti   0.951
 yes  31(14)  3(12.5)
 No 139(62)  16(67)
 Not sure (Discharge) 55(24)  5(20.5)
 missing/unknown 6 1 
Does current partner have another partner      0.574 
 yes 14(7)  3(13)
 No 100(47)  10(43.5)
 Do not know 99(46)  10(43.5)
 missing/unknown 18  2 
is your partner circumcised   0.810
 yes 178(84.4)  20(87)
 No 26(12.3)  3(13)
 Did not know 7(3.3)   0
 missing/unknown  20  2 
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Association between sexual behaviour and hpv 
status was not statistically different between 
study participants who were hpv negative and 
HPV positive. The factors were: age at first sexual 
intercourse, number of lifetime partners, sexual 
partners last six months, frequency of intercourse 
per week, practice douching after sex, ever treated 
for an sti, if current partner has another partner, if 
partner was circumcised (table 2). of those who tested 
positive only two reported having had more than one 
sexual partner while in six there was no response on 
the number of sexual partners, this number is small 
and a conclusion of increased vulnerability may not 
be made from it.
DiscussioN
two hundred and sixty four adolescent girls were 
enrolled in this study to determine among other things 
the DNA genotype in those who were positively 
identified to have HPV infection, using the PCR 
test. the study was carried out at the KNh youth 
clinic. this is a youth friendly clinic which was set 
up to specifically target the youth where their needs 
would be addressed by those trained to handle this 
age group.
 the prevalence of cervical hpv infection as 
defined by a positive HPV DNA test was found to have 
been 9 % among the adolescent girls. this prevalence 
is lower than the World health organisation estimates 
for hpv infection in the African countries of  22 % 
(5) and also compared to the findings of a study in 
Kenyans done among a high risk population of men 
around lake victoria of 53 % (6).  similar study done 
in gambia, West Africa has shown that the prevalence 
of cervical hpv infection among girls aged 15-24 years 
was 15 %( 36). the mean age in our study was 22.6 
years, this compares favourably with the findings of 
the study in gambia. 
 The findings of the low prevalence in this study 
though encouraging  is still of concern considering 
the possible complications of hpv infections since 
more than 90% of adolescent girls aged between 12 
and 26 years are at risk of hpv infection. the mean 
age of the youth with positive hpv infection was 
22.6 years. this is the age when there is increased 
sexual activity and peer pressure plays a big role 
in influencing sexual behaviour. much higher hpv 
prevalence figures have been reported in some 
unselected studies from eastern and southern Africa, 
ranging from 34% in rural Zimbabwe (36) to 44% in 
urban Kenya population who were already considered 
as a high risk group (37).    
 in this study a total of eight different subtypes 
were detected using the PCR method. Twenty five 
samples (9.8%) were hpv-DNA-positive by pcr. A 
total of eight different hpv sub-types were detected. 
of the positive samples, (16%) were positive for a 
single hpv type, 17 (68%) were samples containing 
more than one hpv type (mixed: 32%, two types 
and 16%, three types).  the most prevalent hpv 
types were hr types 18 and 66. An uncharacterised 
type was found in 16% of the hpv-positive samples. 
in this study hpv type 16 was not among the most 
frequent hpv sub-type.  
 This is an important finding since there was no 
low risk type of hpv isolated from the positive group 
and the number of mixed sub-types isolated was 
higher than the individual sub-types. this would, 
therefore, call for more work to be done on the role 
the other sub-types of hpv especially 66 other than 
the types 16 and 18 would be contributing towards 
the development of invasive cancers in our region.
there is also the need to compare the subtypes seen 
in the adolescent and adult if there is similarity or if 
age may have a factor in the sub-type of hpv infection 
seen in our region.
 the primary prevention of hpv infection is the 
use of the available vaccines of which two are available 
in the market cervarix and gardasil, studies done in 
Nairobi in 2010 looking into the vaccine administration 
acceptance by parents showed that only 58% were 
willing to have their daughters vaccinated and their 
main concern was the lack of adequate information on 
the vaccine use. this then calls for increased advocacy 
to the population especially through the schools (27). 
majority of those seen in the KNh youth clinic are 
still in schools and, therefore, the need for increased 
awareness of hpv vaccine use for the prevention of 
invasive cervical cancer in this group is important.
in conclusion, the prevalence of hpv among 
adolescents being cared for at KNh was 9.8% and 
the most prevalent sub-types were the hr hpv types 
18 and 66. A national study should be conducted to 
determine the national prevalence of hpv infection. 
there is need of advocacy on hpv infection prevention 
through vaccine use. 
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